Cargando…
Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The...
Autores principales: | Kim, Jewel Ju Ea, Kocsmár, Ildikó, Buzás, György Miklós, Szirtes, Ildikó, Rusz, Orsolya, Diczházi, Csaba, Szijártó, Attila, Hritz, István, Schaff, Zsuzsa, Kiss, András, Kocsmár, Éva, Lotz, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275651/ https://www.ncbi.nlm.nih.gov/pubmed/34267605 http://dx.doi.org/10.3389/pore.2021.1609863 |
Ejemplares similares
-
Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides
por: Kocsmár, Éva, et al.
Publicado: (2021) -
Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer
por: Szalai, Luca, et al.
Publicado: (2022) -
Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors
por: Kocsmár, Éva, et al.
Publicado: (2020) -
Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer
por: Kocsmár, Ildikó, et al.
Publicado: (2022) -
Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis
por: Kouhsari, Ebrahim, et al.
Publicado: (2022)